Ticker Scorecard - DAWN Basics Company: Day One Biopharmaceuticals, Inc. IPO Date: May 27, 2021 Sector: Healthcare Industry: Biotech Market Cap: $1.25B Activated in VL: True Average Daily Range Avg Daily Range: $0.46 | 2.85% Avg Daily Range (30 D): $0.25 | 2.08% Avg Daily Range (90 D): $0.28 | 2.06% Institutional Daily Volume Avg Daily Volume: .62M Avg Daily Volume (30 D): .85M Avg Daily Volume (90 D): .88M Trade Size Avg Trade Size (Sh.): 83 Avg Trade Size (Sh.) (30 D): 75 Avg Trade Size (Sh.) (90 D): 81 Institutional Trades Total Inst.Trades: 1,336 Avg Inst. Trade: $1.63M Avg Inst. Trade (30 D): $1.13M Avg Inst. Trade (90 D): $1.54M Avg Inst. Trade Volume: .11M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.95M Avg Closing Trade (30 D): $1.21M Avg Closing Trade (90 D): $1.68M Avg Closing Volume: 129.01K     News Oct 22, 2024 @ 6:33 PM Global Cancer Antibody Drug Conjugates Market Size... Source: Kuick Research Jun 19, 2024 @ 2:29 PM Day One (DAWN) In-Licenses MabCare Cancer Candidat... Source: Zacks Equity Research Jun 18, 2024 @ 12:30 PM Day One Expands Pipeline with Potential First-in-C... Source: Day One Biopharmaceuticals, Inc. May 30, 2024 @ 12:30 PM Day One Announces Sale of Priority Review Voucher ... Source: Day One Biopharmaceuticals, Inc. May 6, 2024 @ 8:30 PM Day One Reports First Quarter 2024 Financial Resul... Source: Day One Biopharmaceuticals, Inc. Financials   TTM Q3 2024 Q2 2024 Basic EPS $-1.03 $.38 $-.05 Diluted EPS $-1.03 $.38 $-.05 Revenue $ 101.95M $ 93.76M $ 8.19M Gross Profit $ $ $ Net Income / Loss $ -120.45M $ .88M $ -4.41M Operating Income / Loss $ -211.46M $ 29.64M $ -114.81M Cost of Revenue $ $ $ Net Cash Flow $ 181.59M $ 183.15M $ -30.78M PE Ratio